Xiaofeng Zou

Xiaofeng Zou

Auto-generated profile, based on publicly available information

Xiaofeng Zou

Department of Urology, First Affiliated Hospital of Gannan Medical University, Ganzhou, China

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2012 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
YXYi-Jun Xue
Yi-Jun Xue
RXRi-Hai Xiao
Ri-Hai Xiao
DLDa-Zhi Long
Da-Zhi Long
XZXiao-Feng Zou
Xiao-Feng Zou
XWXiao-Ning Wang
Xiao-Ning Wang
MLMin Liu
Min Liu
Background: Fork head box M1 (FoxM1) is a proliferation-associated transcription factor essential for cell cycle progression. Numerous studies have documented that FoxM1 has multiple functions in tumorigenesis and its elevated levels are frequently associated with cancer progression. The present study was conducted to investigate the expression of FoxM1 and its prognostic significance in clear cell renal cell carcinoma (ccRCC). Meanwhile, the function of FoxM1 in human ccRCC was further investigated in cell culture models. Methods: Real-time quantitative PCR, western blot and immunohistochemistry were used to explore FoxM1 expression in ccRCC cell lines and primary ccRCC clinical specimens. FoxM1 expression was knocked down by small interfering RNA (siRNA) in Caki-1 and 786-O cells; proliferation, colony formation, cell cycle, migration, invasion, and angiogenesis were assayed. Results: FoxM1 expression was up-regulated in the majority of the ccRCC clinical tissue specimens at both mRNA and protein levels. Clinic pathological analysis showed that FoxM1 expression was significantly correlated with primary tumor stage (P <0.001), lymph node metastasis (P = 0.01), distant metastasis (P = 0.01), TNM stage (P < 0.001) and histological grade (P = 0.003). The Kaplan–Meier survival curves revealed that high FoxM1 expression was associated with poor prognosis in ccRCC patients (P < 0.001). FoxM1 expression was an independent prognostic marker of overall ccRCC patient survival in a multivariate analysis (P = 0.008). Experimentally, we found that down-regulation of FoxM1 inhibited cell proliferation and induced cell cycle arrest with reduced expression of cyclin B1, cyclin D1, and Cdk2, and increased expression of p21 and p27. Also, down-regulation of FoxM1 reduced expression and activity of matrix metalloproteinase-2 (MMP-2), MMP-9 and vascular endothelial growth factor (VEGF), resulting in the inhibition of migration, invasion, and angiogenesis. Conclusions: These results suggest that FoxM1 expression is likely to play important roles in ccRCC development and progression, and that FoxM1 is a prognostic biomarker and a promising therapeutic target for ccRCC.

3 January 2024 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
GZGuoxi Zhang
Guoxi Zhang
JZJunrong Zou
Junrong Zou
JSJinglin Shi
Jinglin Shi
BQBiao Qian
Biao Qian
KQKaiyang Qiu
Kaiyang Qiu
XZXiaofeng Zou Xiaofeng Zou
Xiaofeng Zou Xiaofeng Zou

4 March 2014 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
YXY Xue
Y Xue
GWG Wu
G Wu
YLY Liao
Y Liao
GXG Xiao
G Xiao
XMX Ma
X Ma
RHR Huang
R Huang
Golgi phosphoprotein 3 (GOLPH3) has been reported to be involved in the development of several human cancers. The present study was conducted to investigate the expression of GOLPH3 and its prognostic significance in renal cell carcinoma (RCC). Meanwhile, the function of GOLPH3 in human RCC was further investigated in cell culture models. Expression of GOLPH3 was examined in 43 fresh RCC tissues and paired adjacent normal renal tissues by real-time quantitative PCR and western blotting. Immunohistochemistry for GOLPH3 was performed on additional 218 RCC tissues. The clinical significance of GOLPH3 expression was analysed. Downregulation of GOLPH3 was performed using small-interfering RNA (siRNA) in Caki-1 and 786-O cells with high abundance of GOLPH3, and the effects of GOLPH3 silencing on cell proliferation, migration, invasion in vitro, and tumour growth in vivo were evaluated. Expression of GOLPH3 was upregulated in the majority of the RCC clinical tissue specimens at both mRNA and protein levels. Clinicopathological analysis showed that GOLPH3 expression was significantly correlated with T stage (P<0.001), lymph-node status (P=0.003), distant metastasis (P<0.001), tumour-node-metastasis (TNM) stage (P<0.001), and Fuhman grade (P=0.001). Expression of GOLPH3 was inversely correlated with both overall and recurrence-free survival of RCC patients. Multivariate analysis showed that GOLPH3 expression was an independent prognostic indicator for patient’s survival. Knockdown of the GOLPH3 expression reduced cell proliferation, anchorage-independent growth, migration, invasion, and tumour growth in xenograft model mice. These results suggest that GOLPH3 expression is likely to have important roles in RCC development and progression, and that GOLPH3 is a prognostic biomarker and a promising therapeutic target for RCC.

17 April 2018 in International Journal of Experimental Pathology
Verified
Journal Article
Closed access
PDF file
GZGuoxi Zhang
Guoxi Zhang
XZXiaofeng Zou
Xiaofeng Zou
QLQuanliang Liu
Quanliang Liu
TXTianpeng Xie
Tianpeng Xie
RHRuohui Huang
Ruohui Huang
JZJiaxing Zhu
Jiaxing Zhu

30 December 2012 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
YXYijun Xue
Yijun Xue
GWGengqing Wu
Gengqing Wu
XWXiaoning Wang
Xiaoning Wang
XZXiaofeng Zou
Xiaofeng Zou
GZGuoxi Zhang
Guoxi Zhang
MLMin Liu
Min Liu

3 June 2011 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
XZXiaofeng Zou
Xiaofeng Zou
GZGuoxi Zhang
Guoxi Zhang
RXRihai Xiao
Rihai Xiao
YYYuanhu Yuan
Yuanhu Yuan
GWGengqing Wu
Gengqing Wu
XZXu Zhang
Xu Zhang